Notícias

LEVI accelerates DTC growth as digital gains, customer engagement and retail execution lift sales and raise its 2026 outlook.

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.

FIGS raises its 2026 outlook after strong Q2 growth, with higher revenue and margin targets despite second-half execution risks.

Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Healthcare apparel company Figs (NYSE:FIGS) announced better-than-expected revenue in Q2 CY2026, with sales up 28.8% year on year to $196.6 million. Its non-GAAP profit of $0.11 per share was 66.9% above analysts’ consensus estimates.

Here is how Figs (FIGS) and Dick's Sporting Goods (DKS) have performed compared to their sector so far this year.

Figs stock exploded on Friday -- and is still cheap.

Why FIGS stock moved on fresh earnings news FIGS (FIGS) caught investors’ attention after second quarter 2026 results and a higher full year revenue outlook, combined with an expanded share repurchase plan. Together, these developments framed a clear new information reset for the stock. See our latest analysis for FIGS. FIGS has seen sharp momentum build around this earnings release, with a 1-day share price return of 26.87% and a 30-day share price return of 42.03%, while its 1-year total...

FIGS (NYSE:FIGS) reported second-quarter fiscal 2026 revenue growth of 29% as demand increased across scrub wear, non-scrub apparel, international markets, institutional sales and retail community hubs. The healthcare apparel company also raised its full-year revenue and profitability outlook, despi

The leading apparel brand for healthcare professionals offers investors a lucrative combination of growth and profitability.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3%, and the actively tra

Moby summary of FIGS, Inc.'s Q2 2026 earnings call

Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Capri Holdings (CPRI) delivered earnings and revenue surprises of +67.50% and +2.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

MCD's Q2 earnings beat estimates as stronger franchised margins offset a revenue miss, while comparable sales rise across all three segments.

Since January 2026, Figs has been in a holding pattern, posting a small loss of 0.5% while floating around $10.75. The stock also fell short of the S&P 500’s 7.1% gain during that period.

DPZ's fiscal second-quarter results reflect benefits from order growth across both delivery and carryout channels.

FIGS' record-high net revenues per active customer signal stronger spending, higher purchase frequency and engagement as the company lifts its 2026 outlook.

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.

FIGS shows how healthcare apparel is evolving through essential demand, broader wardrobes, Community Hubs and global growth, despite cost friction.

FIGS' outlook rests on scrubwear strength, rising active customers and a global push, even as tariffs, freight and marketing spending pressure margins.

An analyst maintained her bullish stance on the company following discussions with two executives.

Looking back on consumer discretionary - apparel and accessories stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Figs (NYSE:FIGS) and its peers.

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

FIGS (NYSE:FIGS) reported strong Q1 2026 results, with revenue and profitability exceeding internal expectations. Performance was supported by new product releases, customer growth, and expanding international operations. The company achieved this against a backdrop of tariffs, freight costs, and other macro and operational pressures. For investors watching NYSE:FIGS, the latest quarter lands after a pullback of 29.0% over the past month, alongside a 151.8% gain over the past year. The...

Healthcare apparel company Figs (NYSE:FIGS) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 28% year on year to $159.9 million. Its non-GAAP profit of $0.03 per share was $0.01 above analysts’ consensus estimates.

Figs delivered first quarter results that exceeded Wall Street’s expectations for both revenue and profitability, with management highlighting broad-based product strength and continued growth in new and returning customers. However, the market reacted negatively, with concerns centering on customer acquisition dynamics and external cost pressures. CEO Trina Spear cited “accelerating active customer growth” and successful product launches, but also acknowledged headwinds tied to tariffs and risi